Increase in female liver cancer in the Gambia, West Africa: evidence from 19 years of population-based cancer registration (1988-2006)
- PMID: 21490972
- PMCID: PMC3072390
- DOI: 10.1371/journal.pone.0018415
Increase in female liver cancer in the Gambia, West Africa: evidence from 19 years of population-based cancer registration (1988-2006)
Abstract
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide with a high burden in West Africa. Male to female ratios show consistent bias toward males, the biological bases and variations of which are not well understood. We have used data from the Gambian National Cancer Registry to compare trends in incidence of HCC in both genders.
Methods and findings: Two periods were compared, 1988-1997 (early) and 1998-2006 (recent). In addition, the regression program joinpoint was used to assess trends over 19 years. Differences with self-reported ethnicity were assessed for the recent period using population data from 2003 census. Male to female ratio showed a significant decrease between the two periods from 3.28∶1 (95% CI, [2.93-3.65]) to 2.2∶1 (95% CI, [1.99-2.43]). Although rates in males were relatively stable (38.36 and 32.84 for, respectively, early and recent periods), they increased from 11.71 to 14.9 in females with a significant Annual Percentage Change of 3.01 [0.3-5.8] over 19 years and an increase in number of cases of 80.28% (compared to 26% in males). Significant variations in HCC risk, but not in gender ratio were observed in relation with ethnicity.
Conclusion: This analysis of the only national, population-based cancer registry in West Africa shows a significant increase in HCC in females over recent years. This increase may be the consequence of major changes in lifestyle or viral risk factors, in particular obesity and hepatitis C, which have both been documented to increase in West Africa during recent years.
Conflict of interest statement
Figures



Similar articles
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa.PLoS One. 2013 Sep 30;8(9):e75775. doi: 10.1371/journal.pone.0075775. eCollection 2013. PLoS One. 2013. PMID: 24098724 Free PMC article. Clinical Trial.
-
Cancer in the Gambia: 1988-97.Br J Cancer. 2001 May 4;84(9):1207-14. doi: 10.1054/bjoc.2001.1730. Br J Cancer. 2001. PMID: 11336472 Free PMC article.
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
-
Hepatocellular carcinoma: recent trends in the United States.Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. doi: 10.1053/j.gastro.2004.09.013. Gastroenterology. 2004. PMID: 15508094 Review.
Cited by
-
Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.Front Genet. 2021 Nov 3;12:758725. doi: 10.3389/fgene.2021.758725. eCollection 2021. Front Genet. 2021. PMID: 34804125 Free PMC article.
-
A Practical Approach Based on Analytic Deformable Algorithm for Scenic Image Registration.PLoS One. 2013 Jun 21;8(6):e66656. doi: 10.1371/journal.pone.0066656. Print 2013. PLoS One. 2013. PMID: 23805257 Free PMC article.
-
Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis.Front Oncol. 2020 Feb 28;10:171. doi: 10.3389/fonc.2020.00171. eCollection 2020. Front Oncol. 2020. PMID: 32185125 Free PMC article.
-
AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.Front Oncol. 2021 Sep 14;11:713017. doi: 10.3389/fonc.2021.713017. eCollection 2021. Front Oncol. 2021. PMID: 34595113 Free PMC article.
-
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.Carcinogenesis. 2012 Jun;33(6):1219-24. doi: 10.1093/carcin/bgs068. Carcinogenesis. 2012. PMID: 22759751 Free PMC article.
References
-
- Viviani S, Carrieri P, Bah E, Hall AJ, Kirk GD, et al. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:3216–3223. - PubMed
-
- Parkin DM, Bray F, Ferlay j, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- CANCER Epidemiology and Prevention. Third ed. New York: Oxford University Press; 2006.
-
- Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene. 2007;26:5741–5751. - PubMed
-
- Sighoko D, Bah E, Haukka J, McCormack VA, Aka EP, et al. Population-based breast (female) and cervix cancer rates in The Gambia: evidence of ethnicity-related variations. Int J Cancer. 2010;127:2248–2256. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical